Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

69
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

50
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
50
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

69
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69
What is the Immune System?01:38

What is the Immune System?

100.3K
Overview
100.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the cGAS-STING pathway for therapeutic gain in autoimmune inflammatory cutaneous diseases with a focus on systemic lupus erythematosus and systemic sclerosis.

The British journal of dermatology·2025
Same author

The Role of the Pulmonary Microenvironment in Driving Transition From Systemic Sclerosis to Systemic Sclerosis-Associated Interstitial Lung Disease.

The Journal of rheumatology·2025
Same author

A Long Stretch: IL-11 Drives Skin Regeneration.

The Journal of investigative dermatology·2025
Same author

Extracellular BAG3 is elevated in early diffuse systemic sclerosis.

Military Medical Research·2025
Same author

The metabolic drivers of IFN-γ release: glycolysis and acetyl CoA ride in the front seat.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis.

Journal of dermatological science·2025

Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

917

Innate immunity in systemic sclerosis pathogenesis.

Steven O'Reilly1

  • 1*Musculoskeletal Research Group, Institute of Cellular Medicine, 4th Floor Cookson Building, Framlington Place, Newcastle upon Tyne NE2 4HH, U.K.

Clinical Science (London, England : 1979)
|November 14, 2013
PubMed
Summary

The innate immune system, particularly Toll-like receptors (TLRs), plays a key role in systemic sclerosis (SSc) by promoting fibrosis. Targeting TLRs may offer new treatments for this incurable autoimmune disease.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

22.1K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

9.9K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

917
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

22.1K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

9.9K

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Background:

  • The innate immune system provides a rapid, non-antigen-specific defense against pathogens and endogenous danger signals.
  • Toll-like receptors (TLRs) are pattern recognition receptors crucial for innate immunity, recognizing pathogen-associated molecular patterns and damage-associated molecular patterns.
  • Dysregulation of innate immunity and TLRs is implicated in autoimmune diseases like rheumatoid arthritis (RA) and systemic sclerosis (SSc).

Purpose of the Study:

  • To review the role of the innate immune system and TLRs in the pathogenesis of systemic sclerosis (SSc).
  • To explore the interaction between TLRs, stromal cells, and the development of fibrosis in SSc.
  • To identify potential therapeutic strategies targeting the innate immune system for SSc.

Main Methods:

  • Literature review focusing on the innate immune system, TLRs, and their involvement in SSc.
  • Analysis of molecular mechanisms linking innate immune activation to fibrosis in SSc.
  • Exploration of therapeutic implications of targeting TLR signaling pathways.

Main Results:

  • In SSc, vascular injury and innate immune activation lead to the mobilization of innate lymphoid cells.
  • Activated innate immune cells and resident stromal cells release pro-fibrotic cytokines, promoting fibroblast differentiation into myofibroblasts.
  • TLRs are central mediators in this process, linking innate immune responses to excessive extracellular matrix deposition and fibrosis.

Conclusions:

  • The innate immune system, especially TLRs, significantly contributes to the fibrotic pathology of SSc.
  • Targeting specific components of the TLR signaling cascade presents a promising novel therapeutic avenue for SSc.
  • Further research into innate immunity modulation could lead to treatments for this currently incurable disease.